Senzime AB Sustainability Reports
Senzime AB develops, manufactures, and markets algorithm-powered patient monitoring systems to improve patient safety during and after surgery. Its products include the TetraGraph system for quantitative neuromuscular monitoring and the ExSpiron system for non-invasive respiratory monitoring.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300JQF174JP0MM382
FIGI: BBG001SS4P23
5 reports from 2020 to 2025